Celgene (CELG) option implied volatility, to present new blood cancer, solid tumor clinical data at ASCO

Celgene (NASDAQ: CELG) May call option implied volatility is at 37, June is at 31; compared to its 52-week range of 17 to 38 into announcing that data from more than 60 company-sponsored, cooperative group and investigator-initiated clinical studies evaluating Celgene agents will be presented at the American Society of Clinical Oncology Annual Meeting.

You May Also Be Interested In

• Tesla (TSLA) call put ratio 1 call to 1.1 puts into quarter results
• Ford Motor (F) call put ratio 2 calls to 1 put into quarter results
• Humana (HUM) April weekly option implied volatility into quarter results